Log in to your account:
BMO Sees Technical Weakness in Eli Lilly (LLY) Shares
March 4, 2019 10:36 AM
BMO Capital analyst Alex Arfaei expects some softness in Eli Lilly (NYSE: LLY) following the ELAN exchange in March."We believe ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Eli Lilly & Co. (LLY) Granted FDA Priority Review Designation for Emgality (galcanezumab-gnlm) Injection for Preventive Treatment of Episodic Cluster Headache in Adults
March 5, 2019 6:48 AM